Welcome to our dedicated page for Afya SEC filings (Ticker: AFYA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Want the quickest route to Afya’s essential numbers—tuition per student, newly authorized medical school seats, or digital health margins? Start here. Every Afya document filed with the SEC appears the moment it hits EDGAR, from 20-F annual reports to 6-K interim updates.
Our platform answers the exact questions professionals ask: “Afya insider trading Form 4 transactions”, “Afya quarterly earnings report 10-Q filing”, “Afya proxy statement executive compensation”. AI highlights the KPIs that move valuation—enrollment growth, acquisition earn-outs, SaaS churn—so you can compare quarter over quarter without combing through footnotes.
Need fast context? AI-powered summaries turn dense text into plain language, making Afya SEC filings explained simply. Receive alerts for Afya Form 4 insider transactions real-time, see Afya executive stock transactions Form 4 before the market opens, and explore Afya 8-K material events explained in minutes. Each section links directly to the underlying pages for deeper Afya earnings report filing analysis. Whether you are tracking debt covenants, segment EBITDA, or governance changes, understanding Afya SEC documents with AI means fewer clicks and faster insights.
Forms covered include the Afya annual report 10-K simplified for long-term strategy, 10-Q style 6-Ks for trending results, definitive proxy statements that detail stock options, and every 8-K on acquisitions of new campuses. Real-time search, historical archives, and exportable data complete the workflow so investors, auditors, and educators can make confident decisions.
Afya Limited filed a Form S-8 to register additional Class A common shares for its equity incentive plans. The filing covers 3,393,220 shares authorized for issuance under the Amended and Restated Stock Option Plan and 987,016 shares authorized for issuance under the Restricted Stock Plan.
The registration incorporates by reference Afya’s Annual Report on Form 20-F for the year ended December 31, 2024 and subsequent Exchange Act reports. The shares have a par value of $0.00005 per share. This administrative filing expands the pool of shares available for future grants under the company’s employee equity plans.
Afya Limited filed a Form 6-K reporting an operational update. The company announced a medical seats increase at AFYA Faculdade de Ciências Médicas Bragança, as noted in Exhibit 99.1.
The report was signed by Chief Executive Officer Virgilio Deloy Capobianco Gibbon on November 7, 2025.